Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 3Squamous Cell Carcinoma of Head and Neck 1Meningioma 1Lung Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 3Filgrastim 2Cytarabine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1Therapeutics 1Tacrolimus 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Ketamine 1Interferon-alpha 1Idarubicin 1Hydroxyurea 1Flow Cytometry 1Etoposide 1Decitabine 1Cord Blood Stem Cell Transplantation 1Biopsy 1Antilymphocyte Serum 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Hydroxyurea × Clear all
NCT00025402 2013-12-18

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
1,000 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡